ATOS:US
$0.878
-0.847%

Atossa Therapeutics Inc.
News & Events

Last updated: Jun 11, 2025, 11:44 PM ET

  1. Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference

    PR Newswire JUN 2, 2025 8:45 AM EDT
    Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference PR Newswir...
    READ ARTICLE
  2. Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22

    ACCESS Newswire MAY 20, 2025 9:00 AM EDT
    SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS)...
    READ ARTICLE
  3. Atossa Therapeutics Announces Full Results from I?SPY?2 Endocrine?Optimization Sub?Study Evaluating Low?Dose (Z)?Endoxifen

    PR Newswire MAY 14, 2025 8:15 AM EDT
    Atossa Therapeutics Announces Full Results from I‑SPY 2 Endocrine‑Optimizati...
    READ ARTICLE
  4. Atossa Therapeutics Announces First Quarter 2025 Financial Results and Provides a Corporate Update

    PR Newswire MAY 13, 2025 8:00 AM EDT
    Atossa Therapeutics Announces First Quarter 2025 Financial Results and Provides a Corporate Updat...
    READ ARTICLE
  5. Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281,056, Including 58 Claims Covering Various Formulations for its (Z)-endoxifen Portfolio

    GlobeNewswire APR 30, 2025 8:45 AM EDT
    SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Ato...
    READ ARTICLE
  6. Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025

    GlobeNewswire APR 29, 2025 8:45 AM EDT
    SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Ato...
    READ ARTICLE
  7. Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio

    GlobeNewswire APR 22, 2025 8:45 AM EDT
    SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Ato...
    READ ARTICLE
  8. Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer

    PR Newswire APR 10, 2025 8:00 AM EDT
    Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies f...
    READ ARTICLE
  9. Atossa Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update

    GlobeNewswire MAR 25, 2025 8:00 AM EDT
    Ended 2024 with $71.1 million of cash and cash equivalents and no debt Conference Call an...
    READ ARTICLE
  10. Atossa Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

    GlobeNewswire MAR 20, 2025 9:13 AM EDT
    SEATTLE, March 20, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Ato...
    READ ARTICLE

Upcoming Events

Get notified of Atossa Therapeutics Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement

    Not Available
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available